Navigation Links
Zeus Expands Class 7 Capabilities to Include the Processing of Advanced Polymers
Date:1/4/2011

ORANGEBURG, S.C., Jan. 4, 2011 /PRNewswire/ -- Zeus, Inc., a global leader in material science and high-performance polymer extrusions, announces it has expanded its capabilities and is now able to process Aeos® ePTFE and Electrospun Polymers in a new 5,000-sq-ft Class 7 manufacturing environment. This expansion allows for the processing of these advanced materials in a more controlled environment, resulting in compliance with stricter regulatory standards.

"Medical regulatory bodies are raising the bar on standards for devices in the industry and Zeus is committed to meeting this challenge," said Bob Jennings, Zeus Vice President, Sales and Marketing. "The processing of these advanced materials in a tightly controlled environment ensures that customer products meet the strictest regulatory requirements in the medical device industry."

Zeus is also equipped with a Class 7 Certified 5,000-sq-ft Biomaterials Facility dedicated exclusively to the extrusion, analysis, and characterization of bioabsorbable polymers and other advanced materials. Coupled with the state-of-the-art Biomaterials Facility, this latest Class 7 expansion further boosts Zeus' ability to provide its customers a speed-to-market pathway for their products. This brings Zeus' total Class 7 Certified manufacturing capabilities to 10,000 sq ft of controlled environment operating under ISO 13485 guidelines.

"Zeus is leading the charge in the marketplace by providing support from ideation all the way to polymer characterization for medical device companies," said Bob Ballard, Vice President, Research and Strategic Business Development. "In addition to our ability to process and extrude polymers in a Class 7 environment, we also have a dedicated analytical laboratory that allows us to provide real-time analysis and characterization of polymers while being manufactured."

About Zeus, Inc.:Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in material science and the production of high-performance polymer tubing used in demanding applications, operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, aerospace, and mechanical markets. For more information, visit http://www.zeusinc.com.Press Contact:Samantha D. Farlow-MoydCommunications Coordinator (803) 268-9500publicrelations@zeusinc.comThis press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>

SOURCE Zeus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Crescent Healthcare Expands East Coast Presence
2. YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387
3. Hikma Expands its Global Injectables Business Through the Acquisition of Baxter Healthcare Corporations Multi-Source Injectables Business
4. Hikma Expands its Global Injectables Business - Live Webcast
5. Biostar Pharmaceuticals, Inc. Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500
6. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
7. Beta-Pro Expands Operations to Meet Demands for Human Cells in Hepatocyte Drug Discovery Market
8. iPierian Expands Leadership Team With Experienced Business Development and Intellectual Property Executives
9. Vital Therapies Expands SILVER Trial to Saudi Arabia
10. Launch of Two New Platforms for Microplate Analysis Expands Reader Portfolio and Ensures Molecular Devices Readers Meet all Combinations of Customer Needs
11. China BCT Further Expands its Footprint by Opening 12 New Retail Pharmaceutical Stores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
(Date:5/18/2016)... , May 18, 2016 The ... it does not mean that there are no opportunities ahead. ... Pharmaceuticals Inc. (NASDAQ: THLD ), Seattle Genetics Inc. ... CHMA ), and Ophthotech Corp. (NASDAQ: OPHT ). ... alerts at: http://www.activewallst.com/ Threshold ...
(Date:5/18/2016)... ... May 18, 2016 , ... Ryan Benton was diagnosed with Duchenne ... the late teens to early twenties. DMD is a relatively common progressive genetic disorder, ... of 22, Benton’s condition was critical. He met with the founder of the ...
(Date:5/17/2016)... ... May 17, 2016 , ... ... Conference that they will collaborate to bring a feeding cup to market based ... Dentistry, and the Craniofacial Center at Seattle Children’s Hospital, thereby ensuring an innovative ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/21/2016)... 22, 2016 Unique technology ... for superior security   Xura, ... of secure digital communications services, today announced it is ... offer enterprise customers, particularly those in the Financial Services ... voice authentication within a mobile app, alongside, and in ...
(Date:3/14/2016)... , March 14, 2016 NXTD ) ... mobile commerce market, announces the airing of a new series ... the week of March 21 st .  The commercials will ... its popular Squawk on the Street show. --> ... the growing mobile commerce market, announces the airing of a ...
Breaking Biology News(10 mins):